The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Intranasal Drug Delivery Devices Market Expected To Scale Between 2026 And 2030?
The intranasal drug delivery devices market size has demonstrated significant growth over recent years. This market is anticipated to expand from $65.09 billion in 2025 to $70.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The historical growth can be linked to factors such as the increasing prevalence of respiratory and nasal disorders, the rising adoption of the nasal route for systemic drug delivery, the expansion of self-administration drug devices, a rise in approvals for intranasal therapies, and the broader implementation of outpatient treatment models.
The intranasal drug delivery devices market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $99.11 billion, exhibiting a compound annual growth rate (CAGR) of 8.8%. This projected increase during the forecast period is fueled by several factors, including the rising creation of biologics and vaccines delivered nasally, a growing need for homecare drug management, the wider application of intranasal methods for neurological treatments, increasing capital directed towards sophisticated drug-device combinations, and a greater emphasis on solutions that enhance patient adherence. Key market tendencies expected in this period encompass the wider acceptance of precise nasal delivery systems, an escalating preference for non-invasive drug administration, the ongoing development of multi-dose nasal devices, the proliferation of user-friendly drug delivery options, and an intensified focus on achieving quick drug absorption.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp
What Major Factors Are Driving The Intranasal Drug Delivery Devices Market Forward?
The rising incidence of chronic diseases is anticipated to propel the growth of the intranasal drug delivery devices market going forward. Chronic diseases are defined as conditions lasting a year or more, necessitating ongoing medical attention, restricting daily living activities, or both. Intranasal drug delivery devices are utilized to manage chronic diseases by offering a non-invasive and efficient method for administering medications. They facilitate direct delivery of drugs to the target area, providing convenience, ease of use, and promoting quick absorption. For example, in June 2024, data from the National Health Service, a UK-based government department, revealed that in 2023, the number of individuals in England at risk of developing type 2 diabetes increased to 3,615,330, up from 3,066,330 in 2022, with an additional over half a million (549,000) people identified with non-diabetic hyperglycemia, or pre-diabetes. Consequently, the increasing prevalence of chronic diseases is a significant driver for the growth of the intranasal drug delivery devices market.
How Is The Intranasal Drug Delivery Devices Market Segmented Across Different Segment Categories?
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays
Which Trends Are Impacting The Progress Of The Intranasal Drug Delivery Devices Market?
Leading companies within the intranasal drug delivery devices market are concentrating on developing novel and improved products, such as recyclable polyolefin nasal spray actuators. This focus aims to bolster sustainability, enhance patient compliance, and support eco-friendly drug delivery solutions. A recyclable polyolefin nasal spray actuator is a nasal drug delivery component crafted entirely from polyolefin materials, engineered for multiple-dose administration without any metal parts. For instance, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, unveiled the APF Futurity. This represents the first metal-free multidose nasal spray pump, specifically designed to address the rising demand for highly recyclable packaging. The APF Futurity is manufactured entirely from polyolefin materials, contains no metal components, and possesses a Class AA highly recyclable certification from cyclos-HTP. This pump delivers precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and facilitates sustainable recycling, thereby making it an optimal choice for environmentally conscious drug delivery solutions and patient convenience.
Which Organizations Play A Role In The Intranasal Drug Delivery Devices Market Landscape?
Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.
Get The Full Intranasal Drug Delivery Devices Market Report:
Where Is The Intranasal Drug Delivery Devices Market Primarily Concentrated By Region?
North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Intranasal Drug Delivery Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp
Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company
Nail Salon Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report
Nail Polish Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report
Medical Tubing Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model